Voxsanity

Who may be able to join

Who might be able to join this trial:

You previously received a treatment called ST-920 as part of a separate, related clinical trial
You have agreed and given your consent to take part in this long-term follow-up study

Who may not be able to join:

There are no exclusion criteria for this study, meaning there are no specific reasons listed that would prevent someone from joining

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status

By Invitation

Phase

Not Applicable

Sponsor

Sangamo Therapeutics

Registry

clinicaltrials_gov

Start date

16 August 2021

Est. completion

1 March 2029

Where this trial is recruiting

🇦🇺 Australia 🇨🇦 Canada 🇩🇪 Germany 🇬🇧 United Kingdom 🇺🇸 United States

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

To evaluate long-term safety of ST-920

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov